NGD-4715

From WikiMD.org
Jump to navigation Jump to search

NGD-4715

NGD-4715 (pronounced: en-jee-dee-four-seven-one-five) is a pharmaceutical compound currently under investigation for its potential therapeutic applications.

Etymology

The term "NGD-4715" is an alphanumeric code assigned by the pharmaceutical company during the drug development process. "NGD" stands for "New Generation Drug", while "4715" is a unique identifier for this specific compound.

Description

NGD-4715 is a potent and selective inhibitor of the enzyme indoleamine 2,3-dioxygenase (IDO). IDO is a key regulator of the immune response, and its inhibition can potentially enhance the body's ability to fight off cancer and other diseases.

Therapeutic Applications

NGD-4715 is currently being studied for its potential use in the treatment of various types of cancer, including melanoma, lung cancer, and colorectal cancer. By inhibiting IDO, NGD-4715 may enhance the effectiveness of other cancer treatments, such as chemotherapy and immunotherapy.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski